ANXA1 and lung disorder: Some of the pathways including the TWEAK pathway (TNFSF12-TNFRSF12A), ANXA1-FPR1, and LAMC2-CD44 have been reported previously in lung disease, which play a pivotal role in inflammatory immune mechanisms and immunosurveillance (66–68).